brad rivet  acura pharmaceuticals inc  zoominfocom acur j bradley rivet insider trades for acura pharmaceuticals inc bulletin investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close acura pharmaceuticals inc otc acur go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus acura pharmaceuticals inc market open  quotes are delayed by  min jul    am acur quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high    week low  week high   insider activity individual j bradley rivet mr j b rivet is vice presidentmarketing at acura pharmaceuticals inc he received his undergraduate degree from louisiana state university transactions date shares transaction value copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr robert b jones president chief executive officer  director mr peter a clemens cfo secretary svp  headinvestor relations dr albert w brzeczko vice presidenttechnical affairs mr james f emigh vice presidentcorporate development mr robert a seiser treasurer vice president  controller mr j bradley rivet vice presidentmarketing mr george k ross independent director mr immanuel thangaraj independent director mr bruce f wesson independent director mr william g skelly independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program acan christopher nolan’s ‘dunkirk’ crack china’s market athis type of investing could save the world — just don’t expect outperformance too athese tips can help advisers attract — and keep — high net worth clients aa menacing pattern has revealed itself in the stock market ateaching people how to invest is one of the best marketing moves an adviser can make aa case for buying the freakin’ dip with amazon as the mooch might now say aconsumerdiscretionary sector slides as amazon shares drop on results ashares of newspaper publisher mcclatchy are up more than  a cities where you can buy a huge house for  or less ahow advisers can fight the ‘crisis of trust’ in financial services abreakingstock market opens lower as wall street resumes tech selling loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  air delights  bradley washroom products and accessories hometrack your order contact us newsletter about us  products    msds    credit application    flat rate ground shipping  per order give us a call  air fresheners automist air fresheners select air fresheners microburst  microburst  pump air fresheners tcell air fresheners easy fresh air fresheners ecoair air fresheners fresh products  new restroom essentials autoflushers  retrofit autoflushers  complete automatic faucets manual faucets soap dispensers  sensor soap dispensers  manual waterfree urinal cartridges waterfree urinals hand dryers paper towel dispensers toilet paper dispensers paper products urinal screens  mats hand sanitizers restroom accessories american specialties bobrick accessories bradley accessories autoclean  autojanitor grab bars toilet seat cover disp tampon vending machine napkin disposal restroom entrance signs restroom mirrors baby changing station hospeco products toilet seats repair parts sloan repair parts flushmate parts ts brass products zurn repair parts toilet partition hardware restroom plumbing flush valves commercial toiletsurinals commercial restroom sinks tankless water heaters shower heads hydrotek products valves  backflow wilkins water control watts water safety febco plumbing products facility products elkay plumbing urinal privacy screens wet floor signs facility workplace signs towel combo units paper towel dispensers waste receptacles napkin vendors napkin disposal tissue dispensers seat cover soap dispensers keys and locks multipurpose units hand dryers mirrors shelves grab bars accessories security accessories eyewash stations drench showers eyewash combos safety partsacc customer service track your order catalog request msds information refund policy contact us company information privacy policy site map payment options social media air fresheners  restroom accessories  plumbing products phone     •   fax   copyright copy –  • air delights inc all rights reserved air delights  bradley washroom products and accessories hometrack your order contact us newsletter about us  products    msds    credit application    flat rate ground shipping  per order give us a call  air fresheners automist air fresheners select air fresheners microburst  microburst  pump air fresheners tcell air fresheners easy fresh air fresheners ecoair air fresheners fresh products  new restroom essentials autoflushers  retrofit autoflushers  complete automatic faucets manual faucets soap dispensers  sensor soap dispensers  manual waterfree urinal cartridges waterfree urinals hand dryers paper towel dispensers toilet paper dispensers paper products urinal screens  mats hand sanitizers restroom accessories american specialties bobrick accessories bradley accessories autoclean  autojanitor grab bars toilet seat cover disp tampon vending machine napkin disposal restroom entrance signs restroom mirrors baby changing station hospeco products toilet seats repair parts sloan repair parts flushmate parts ts brass products zurn repair parts toilet partition hardware restroom plumbing flush valves commercial toiletsurinals commercial restroom sinks tankless water heaters shower heads hydrotek products valves  backflow wilkins water control watts water safety febco plumbing products facility products elkay plumbing urinal privacy screens wet floor signs facility workplace signs towel combo units paper towel dispensers waste receptacles napkin vendors napkin disposal tissue dispensers seat cover soap dispensers keys and locks multipurpose units hand dryers mirrors shelves grab bars accessories security accessories eyewash stations drench showers eyewash combos safety partsacc customer service track your order catalog request msds information refund policy contact us company information privacy policy site map payment options social media air fresheners  restroom accessories  plumbing products phone     •   fax   copyright copy –  • air delights inc all rights reserved acura pharmaceuticals inc names j bradley rivet vp of marketing employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       acura pharmaceuticals inc names j bradley rivet vp of marketing tweet   am palatine ilmarketwire  october    highlighted links httpacurapharmcom acura pharmaceuticals inc nasdaq acur a specialty pharmaceutical company innovating abuse deterrent drugs announced that j bradley rivet has been named the companys vice president of marketing effective today since  mr rivet was vice president at effcon laboratories inc where he was responsible for otc product marketing and new product initiatives from concept through commercialization as well as strategic partnering brad brings extensive marketing expertise to acura pharmaceuticals which will be extremely valuable as we prepare for the commercial launch of nexafed our pseudophedrine product featuring impede™ our proprietary abuse deterrent technology said bob jones president  chief executive officer of acura pharmaceuticals prior to his role at effcon mr rivet was manager advertising and promotion for aaipharma wilmington nc with responsibility for businesstobusiness advertising and promotion of the companys services within the pharmaceutical industry from  to  he held various positions of increasing responsibility in pharmaceutical sales consumer product marketing and brand management with burroughs wellcome co mr rivet received a bachelor of science degree from louisiana state university about acura pharmaceuticals acura pharmaceuticals is a specialty pharmaceutical company engaged in the research development and commercialization of product candidates intended to deter medication abuse and misuse utilizing its proprietary aversion and impede technologies in june  the us food and drug administration approved an opioid containing product incorporating the aversion technology the company has a development pipeline of additional aversion technology products including other opioids stimulants and benzodiazepines and its impede technology for pseudoephedrine hydrochloride products forwardlooking statements certain statements in this press release constitute forwardlooking statements within the meaning of the private securities litigation reform act of  such forwardlooking statements involve known and unknown risks uncertainties and other factors which may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by such forwardlooking statements forwardlooking statements may include but are not limited to the ability of pfizer to whom we have licensed our aversion® technology for certain opioid analgesic products in the united states canada and mexico to successfully launch and commercialize such products the ability of pfizer and the ability of other pharmaceutical companies if any to whom we may license our aversion technology or impede technology to obtain necessary regulatory approvals and commercialize products utilizing such technologies and the market acceptance of such products expectations regarding potential market share for our products our ability to enter into additional license agreements for our other product candidates the ability to avoid infringement of patents trademarks and other proprietary rights of third parties and the ability of our patents to protect our products from generic competition and the ability to fulfill the us food and drug administrations or fda requirements for approving our product candidates for commercial manufacturing and distribution in the united states including without limitation the adequacy of the results of the laboratory and clinical studies completed to date and the results of laboratory and clinical studies we may complete in the future to support fda approval of our product candidates the adequacy of the development program for our product candidates including whether additional clinical studies will be required to support fda approval of our product candidates changes in regulatory requirements adverse safety findings relating to our product candidates whether the fda will agree with our analysis of our clinical studies and how it may evaluate the results of these studies or whether further studies of our product candidates will be required to support fda approval whether or when we are able to obtain fda approval of labeling for our product candidates for the proposed indications or for abuse deterrent features and whether our product candidates will ultimately deter abuse in commercial settings in some cases you can identify forwardlooking statements by terms such as may will should could would expects plans anticipates believes estimates projects predicts potential and similar expressions intended to identify forwardlooking statements these statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties given these uncertainties you should not place undue reliance on these forwardlooking statements we discuss many of these risks in greater detail in our filings with the securities and exchange commission contactstephanie marks for acura investor relationssmarkslazarpartnerscom rachel kessler for acura media relationsrkesslerlazarpartnerscom digg this    bookmark with delicious    add to newsvine read at biospacecom related news acura pharmaceuticals inc awarded key us patent for abuse deterrent drug formulations takeda pharmaceutical co ltd tkdgde completes euro  billion acquisition and names new ceo of nycomed robert jones appointed president  ceo and to the board of directors of acura pharmaceuticals inc lycera appoints senior life sciences executive kathleen m metters phd as president and chief executive officer acura pharmaceuticals inc receives  million milestone payment from pfizer inc pfe australian anticancer drug company immune system therapeutics limited moves to reach international markets with appointment of new chief executive officer pfizer inc pfe acura pharmaceuticals inc abuseresistant painkiller gets fda nod axogen inc lect announces completion of merger name change and executive team changes acura pharmaceuticals inc reports nd qtr  financial results and product development update viropro inc vpro appoints michelle peake to chief executive officer of alpha biologics sdn bhd absb subsidiary based in penang malaysia please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • acura pharmaceuticals inc   • biotechpharma  personnel                 microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft j bradley rivet  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in j bradley rivet vice president marketing at acura pharmaceuticals inc view full profile are you j bradley rivet claim your profile   sign up for equilar atlas and view j bradley rivets full profile with equilar atlas you can identify corporate executives in j bradley rivets network and community follow changes in j bradley rivets employment and moneyinmotion connect with j bradley rivet through your network of contacts j bradley rivets executive work history current vice president marketing acura pharmaceuticals inc past to view j bradley rivets complete executive work history sign up now education bs louisiana state university age      j bradley rivets biography j bradley rivet has been vice president of marketing since october  prior to such time mr rivet was vice president of effcon laboratories inc mr rivet has also held various management positions with aaipharma inc and burroughs welcome co mr rivet received his bachelor of science degree from louisiana state university age  source acura pharmaceuticals inc on    sign up for equilar atlas and view j bradley rivets full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like j bradley rivet more specifically youll be able to identify corporate executives in j bradley rivets network and community follow changes in j bradley rivets employment and moneyinmotion connect with j bradley rivet through your network of conections view full profile   search for over  executive profiles bio example j bradley rivet j bradley rivets connections  sign up now to view j bradley rivets  connections » james f emigh vice president corporate development acura pharmaceuticals inc george k ross board member acura pharmaceuticals inc immanuel thangaraj board member acura pharmaceuticals inc peter a clemens senior vice president chief financial officer and secretary acura pharmaceuticals inc robert b jones dir president and chief executive officer acura pharmaceuticals inc william g skelly board member acura pharmaceuticals inc robert a seiser vice president corporate controller and treasurer acura pharmaceuticals inc bruce f wesson independent director acura pharmaceuticals inc albert w brzeczko vice president technical affairs acura pharmaceutical technologies inc acura pharmaceuticals inc david f azad former board member acura pharmaceuticals inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft management  acura pharmaceuticals home company need for abuse deterrent products platforms technologies technology platforms aversion® impede® limitx™ market opportunity market opportunity partnerships advocacy groups patents business development product portfolio product pipeline oxaydo® nexafed® product line limitx™ products under development important safety info clinical medical meeting calendar investors investors press releases news  events corporate governance management directors committees contactboard financial information sec filings quarterly results key ratios stock information historic stock lookup investment calculator analyst coverage ownership profile contact us   acura contact us   management name position robert b jones president  chief executive officer peter a clemens senior vice president chief financial officer james f emigh rph vice president corporate development robert a seiser cpa vice president treasurer and corporate controller albert w brzeczko phd vice president technical affairs j bradley rivet vice president marketing ronald l leech senior director quality  analytical chemistry john g gilkay pe director of ehs  engineering gregory a spinner director of logistics and special projects robert b jones peter a clemens james f emigh rph robert a seiser cpa albert w brzeczko phd j bradley rivet ronald l leech john g gilkay pe gregory a spinner robert b jones president  chief executive officer bob has been our president  ceo since july  and served in that capacity on an interim basis since may  after the passing of andy reddick in april  bob previously served as senior vice president and chief operating officer since he joined acura in april   from may  to march  mr jones served first as the vice president finance and then as vice president strategy and business analysis of adolor corporation  from november  to may  he served as vice president finance and then as chief operating officer of optescript inc a privately held personalized medicine company where mr jones was responsible for all commercialization activities  prior to that mr jones was vice president sales and marketing for purepac pharmaceutical company  mr jones received his mba from the university of north carolina and a bs from cornell university peter a clemens senior vice president chief financial officer pete has been senior vice president chief financial officer and secretary since april  mr clemens was our vice president chief financial officer and secretary from february  to march  and a member of our board of directors from june  to august  mr clemens is a certified public accountant and earned a bachelor of business administration degree from the university of notre dame and a masters of business administration from indiana university james f emigh rph vice president corporate development jim has been vice president corporate development since october  prior to that mr emigh was our vice president of marketing and administration from april  through september  mr emigh joined the company in may  serving first as executive director of customer relations then as vice president of operations until november  and as vice president of sales and marketing until march  mr emigh holds a bachelor of pharmacy degree from washington state university and a masters of business administration from george mason university robert a seiser cpa vice president treasurer and corporate controller bob has been vice president treasurer and corporate controller since april  mr seiser joined us in march  as our treasurer and corporate controller mr seiser is a certified public accountant and earned a bachelor of business administration degree from loyola university of chicago albert w brzeczko phd vice president technical affairs al has been vice president technical affairs since february   from  through  dr brzeczko was vice president global pharma new product development and pharma technologies for international specialty products inc a contract services group specializing in the development of technologies for the bioenhancement of poorly soluble drugs  prior to  dr brzeczko held various positions of increasing responsibility in pharmaceutical product development with upm pharmaceuticals banner pharmacaps mylan laboratories and dupont merck  dr brzeczko received a bachelor of science degree in biochemistry and a phd in pharmaceutical sciences from the university of maryland j bradley rivet vice president marketing brad has been vice president of marketing since october  before joining acura mr rivet was vice president at effcon laboratories inc where he was responsible for otc product marketing and new product initiatives from concept through commercialization since  prior to his employment at effcon mr rivet was manager advertising and promotion for aaipharma in wilmington nc from  to  he held various positions of increasing responsibility in pharmaceutical sales consumer product marketing and brand management with burroughs wellcome co mr rivet received a bachelor of science degree from louisiana state university ronald l leech senior director quality  analytical chemistry ron has been the senior director quality  analytical chemistry since may   prior to that time he was director of analytical chemistry  ron’s current responsibilities include leadership of the company’s programs for analytical method development and validation quality control quality assurance and product stability testing  prior to joining the company in april  ron held positions at ilex oncology dpt laboratories and ppdpharmaco  his background includes biopharmaceutical oncology development of novel dermatological products for use in the field of burn management contract manufacturing contract analytical services and medical devices  ron holds a bs degree in biochemistry from edgewood college in madison wi john g gilkay pe director of ehs  engineering john has been the director of ehs  engineering since april   prior to that time he was director environmental affairs health and safety at our culver indiana facility from september  until joining the company in april  he was employed by laidlaw environmental servicessafetykleen managing environmental multimedia health and safety and transportation compliance for several facilities in southern california  john has also held positions with johnson  johnson merck cpc wr grace and angus biotech in a variety of production engineering and ehs compliance roles he is a licensed professional engineer and holds a bs degree in chemical engineering from the university of wisconsin gregory a spinner director of logistics and special projects greg has been director of logistics and special projects since april  prior to that time he served the company as director of supply chain management and  financial controller for operations facilities  prior to joining the company in august  greg was employed by transfer drivers inc and morgan drive away inc as an accountant and divisional controller greg holds a ba degree in accounting from western michigan university   search for pages acura website privacy policy advocacy business development company overview about acura contacts facilities management compensation committee charter corporate audit committee of the board of directors charter code of ethics compensation committee charter investors forward looking statements presentations webcasts  media risk factors sec filings sec filings stock price limitx™ products in development market opportunity medical meeting calendar need for abuse deterrent products nexafed® pseudoephedrine hci tablets oxaydo® oxycodone hcl usp cii tablets partnerships patents product pipeline technology platforms terms of use and privacy policy  no title product candidates acuracet® tablets acurox® with niacin tablets extraction testing study apadf study apadf study apadf study apadf study apadf study apadf study apadf study apadf study apadf study apadf study apadf syringeability testing aversion® hydrocodone bitartrate  acetaminophen tablets important safety info terms of use platforms aversion® technology intentional swallowing intravenous injection nasal snorting impede® technology limitx™ technology archives categoriesno categories meta log in valid xhtml xfn wordpress copyright   acura pharmaceuticals all rights reserved terms of use and privacy policy risk factorscontact us acura pharmaceuticals inc names j bradley rivet vp of marketinghomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchskip to navigationskip to main contentskip to related contentacura pharmaceuticals inc names j bradley rivet vp of marketingmarketwireoctober  reblogsharetweetsharepalatine ilmarketwire  acura pharmaceuticals inc nasdaq acur  news a specialty pharmaceutical company innovating abuse deterrent drugs announced that j bradley rivet has been named the companys vice president of marketing effective today since  mr rivet was vice president at effcon laboratories inc where he was responsible for otc product marketing and new product initiatives from concept through commercialization as well as strategic partneringbrad brings extensive marketing expertise to acura pharmaceuticals which will be extremely valuable as we prepare for the commercial launch of nexafed our pseudophedrine product featuring impede™ our proprietary abuse deterrent technology said bob jones president  chief executive officer of acura pharmaceuticalsprior to his role at effcon mr rivet was manager advertising and promotion for aaipharma wilmington nc with responsibility for businesstobusiness advertising and promotion of the companys services within the pharmaceutical industry from  to  he held various positions of increasing responsibility in pharmaceutical sales consumer product marketing and brand management with burroughs wellcome co mr rivet received a bachelor of science degree from louisiana state universityabout acura pharmaceuticalsacura pharmaceuticals is a specialty pharmaceutical company engaged in the research development and commercialization of product candidates intended to deter medication abuse and misuse utilizing its proprietary aversion and impede technologies in june  the us food and drug administration approved an opioid containing product incorporating the aversion technology the company has a development pipeline of additional aversion technology products including other opioids stimulants and benzodiazepines and its impede technology for pseudoephedrine hydrochloride productsforwardlooking statements certain statements in this press release constitute forwardlooking statements within the meaning of the private securities litigation reform act of  such forwardlooking statements involve known and unknown risks uncertainties and other factors which may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by such forwardlooking statements forwardlooking statements may include but are not limited to the ability of pfizer to whom we have licensed our aversion® technology for certain opioid analgesic products in the united states canada and mexico to successfully launch and commercialize such products the ability of pfizer and the ability of other pharmaceutical companies if any to whom we may license our aversion technology or impede technology to obtain necessary regulatory approvals and commercialize products utilizing such technologies and the market acceptance of such products expectations regarding potential market share for our products our ability to enter into additional license agreements for our other product candidates the ability to avoid infringement of patents trademarks and other proprietary rights of third parties and the ability of our patents to protect our products from generic competition and the ability to fulfill the us food and drug administrations or fda requirements for approving our product candidates for commercial manufacturing and distribution in the united states including without limitation the adequacy of the results of the laboratory and clinical studies completed to date and the results of laboratory and clinical studies we may complete in the future to support fda approval of our product candidates the adequacy of the development program for our product candidates including whether additional clinical studies will be required to support fda approval of our product candidates changes in regulatory requirements adverse safety findings relating to our product candidates whether the fda will agree with our analysis of our clinical studies and how it may evaluate the results of these studies or whether further studies of our product candidates will be required to support fda approval whether or when we are able to obtain fda approval of labeling for our product candidates for the proposed indications or for abuse deterrent features and whether our product candidates will ultimately deter abuse in commercial settings in some cases you can identify forwardlooking statements by terms such as may will should could would expects plans anticipates believes estimates projects predicts potential and similar expressions intended to identify forwardlooking statements these statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties given these uncertainties you should not place undue reliance on these forwardlooking statements we discuss many of these risks in greater detail in our filings with the securities and exchange commissionreblogsharetweetsharepopular in the communityman says he killed wife aboard cruise ship because she would not stop laughing at me affidavit reactionswomen need to carry this device with themsiren songsponsoreddozens injured in barcelona commuter train crash reactionsmario cantone perfectly captures trumps new bff anthony scaramucci reactionstrump administration reportedly threatens alaska over senator’s health care vote reactionstrunk club making sense of styletrunk clubsponsoredclashes in venezuela ahead of sunday’s election reactionsthe note the end for repeal and replace reactionsluis fonsi on justin biebers spanish despacito hitting no  reactionszuckerberg wifes ambitious secret finally exposedunewzmesponsoredsenate skinny repeal of obamacare falls apart on senate floor after mccain defects reactionsgrandmother lays in pool of blood playing dead after being attacked night before her husbands funeral reactionstrump’s unwitting legacy could be universal health coverage reactionsthis is why you dont mess with chinahistoryinorbitsponsoredportugal battles raging wildfires reactionsinsomniac theater atomic blonde and the emoji movie reactionsus would utterly destroy north korea military says top army officialryan yes we could do what he said but not before north korea utterly destoryed seoul killing hundreds of thousands thats not even considering if they use a nukejoin the conversation   american handmade handbags made by military spouses canvas  leather cart  checkout    handbags view all crossbody shoulder tote travel collections new arrivals signature fall signature  seasonal signature limited edition post to pillar special edition wool accessories jewelry scarves apparel leather goods home bath  body pillows  blankets entertaining organization wall decor about us our story meet the team our process r riveter gives back become a riveter press blog gift certificates military branch collections army marine corps navy air force coast guard our mission provide flexible mobile income how we do it raw materials are shipped to remote riveters across the country view our process riveters create the parts  ship to our fabshop just outside of ft bragg nc meet the riveters pieces go into production where they are assembled  inspected final units are shipped to our retail store or directly to our customers featured blogs fall  top  inspirations for the rriveter fall  collection from rriveter cofounder cameron cruse july   continue reading empowered women empower lana gibson july   continue reading   featured on menu search contact us customer help center about us become a riveter privacy policy log in to account    handbags collections accessories home about us blog gift certificates military branch collections   r riveter powered by shopify